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Multipotent blood progenitor cells migrate into the thymus and initiate the T-cell differenti-
ation program. T-cell progenitor cells gradually acquire T-cell characteristics while shedding
their multipotentiality for alternative fates. This process is supported by extracellular signal-
ing molecules, including Notch ligands and cytokines, provided by the thymic microenvi-
ronment. T-cell development is associatedwith dynamic change of gene regulatory networks
of transcription factors, which interact with these environmental signals. Together with
Notch or pre-T-cell-receptor (TCR) signaling, cytokines always control proliferation, survival,
and differentiation of early T cells, but little is known regarding their cross talk with tran-
scription factors. However, recent results suggest ways that cytokines expressed in distinct
intrathymic niches can specifically modulate key transcription factors. This review discusses
how stage-specific roles of cytokines and transcription factors can jointly guide development
of early T cells.
The thymus is the organ specialized tomake Tcells. T cells originate from hematopoietic
stem and precursor cells in the bone marrow
or fetal liver, which migrate to the thymus and
acquire T-cell identity. Relatively small numbers
of T-cell progenitors migrate into the thymus
per day, but they respond to the new environ-
ment by undergoing multiple rounds of prolif-
erationwhile initiating the T-cell differentiation
program (Rothenberg 2000; Petrie and Zuniga-
Pflucker 2007; Rothenberg et al. 2008; Love and
Bhandoola 2011; Naito et al. 2011; Thompson
and Zu´n˜iga-Pflu¨cker 2011; Rothenberg 2014;
Yui and Rothenberg 2014). They then undergo
T-cell lineage commitment, begin T-cell recep-
tor (TCR) rearrangements, and thus generate
abTCR- or gdTCR-expressing T cells. The ab
T cells further diverge into different sublin-
eages, such as CD4 T cells, CD8 T cells, natural
killer T (NKT) cells and regulatory T (Treg)
cells, ultimately to act as a “conductor” of the
immune system “orchestra.”
Thymocytes are divided into multiple phe-
notypically distinct stages that are defined by
the expression of CD4, CD8, and other markers
(Hayday and Pennington 2007; Rothenberg
et al. 2008; Yang et al. 2010; Naito et al. 2011;
Yui and Rothenberg 2014). T-cell development
is initiated from the subpopulation that lacks
the expression of both CD4 and CD8, thus
called double-negative (DN) cells, which then
become CD4þ CD8þ double-positive (DP) and
subsequently differentiate into mature CD4
or CD8 single-positive (SP) cells. The earliest
T-cell precursors in the thymus, called early
thymic progenitor (ETP) or Kit-high double-
negative 1 (KITþþ DN1; CD44þ CD252), still
harbor the potential to gain access to non-T
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alternative fates. These cells start expressing
T-cell markers in the next stage, DN2a (KITþþ
CD44þ CD25þ), but commitment to the T-cell
lineage occurs only at the following stage, DN2b
(Kitþ CD44þ CD25þ). Then in the DN3a
(KIT2 CD442 CD25þ) stage, TCRb gene rear-
rangement begins. This process enables some
cells to express either a pre-TCR (TCRb with
invariant pre-TCRa) or a gdTCR. Pre-TCR-
mediated signal transduction triggers transition
of DN3a cells through DN3b into DN4 (Kit2
CD442CD252), followed by progression to the
DP stage. DP thymocytes undergo TCRa gene
rearrangement and begin to express fully assem-
bled abTCR. Then, they are subjected to a
selection process, which is known as positive se-
lection, to identify cells that express TCR with
potentially useful ligand specificities. Positively
selected thymocytes are allowed to differentiate
into either CD4 helper T cells or CD8 cytotoxic
T cells, known as CD4/CD8-lineage choice.
The special feature of the thymic cortical
environment is its dense presentation of Notch
ligand, primarily Delta-like ligand 4 (DLL4)
(Love and Bhandoola 2011). Very early in the
ETP stage, T-cell precursors become not only
influenced by Notch-DLL4 interaction but de-
pendent on it for optimal growth and survival.
NOTCH1molecules on the surface of lymphoid
precursors interactwithDLL4on thymic stromal
cells, driving lymphoid precursors to initiate the
T-cell-specific developmental program. Engage-
ment of cell-surface NOTCH1 by environmental
Notch ligands triggers the proteolytic release of
intracellular NOTCH1, which travels to the nu-
cleus to become a direct coactivator of DNA-
bound recombining binding protein suppressor
of hairless (RBPJ) and stimulates the expression
of Notch target genes (Radtke et al. 2010). All of
the events that establish the T-cell identity of
precursors are driven directly or indirectly by
Notch signaling (Schmitt and Zuniga-Pflucker
2002; Thompson and Zu´n˜iga-Pflu¨cker 2011).
THREE PHASES OF EARLY T-CELL
DEVELOPMENT
Early T-cell precursor development can be di-
vided usefully into three phases inwhich the first
two depend on Notch signaling and the third
depends on signals from the pre-TCR. The first
Notch-dependent phase involves the expansion
of uncommitted T-cell precursors. The second
Notch-dependent phase establishes the compe-
tence of the cells to express and depend on TCR
complexes. The third phase, much less Notch-
dependent, expands cells with well-assembled
pre-TCR complexes and prepares them for
full immunological repertoire selection. These
stages of differentiation are shown in Figure 1.
Phase 1
Under the influence of Notch signaling, the ETP
cells that are derived from KIThi interleukin-7
receptor (IL-7R)low precursors develop into
KIThi IL-7Rhi DN2a cells before undergoing T-
cell commitment. Cytokines made by the thymic
stroma act as growth factors for them and sup-
port extensive proliferative expansion of precom-
mitment precursors (Love and Bhandoola 2011;
Yui and Rothenberg 2014). Notch signaling not
only turns on canonical Notch target genes such
as Hes1, but also initiates the expression of the
crucial T-cell specification factor coding genes
Gata3 and Tcf7 (encoding TCF1 protein). Even
before the cells are committed, ETP and DN2a
cells begin to express some T-cell-specific genes.
Together withNotch signaling,GATA3andTCF1
antagonize the progenitor-specific factors in
these pro-T cells and regulate specification and
commitment of T cells (Rosenbauer et al. 2006;
Hosoya et al. 2009; Germar et al. 2011; Weber
et al. 2011; DeObaldia et al. 2013b;Garcia-Ojeda
et al. 2013; Scripture-Adams et al. 2014).
Phase 2
Transcriptome analysis of developing T cells
shows that the commitment-linked transition
from phase 1 to phase 2 is marked by a large
numberof positive and negative gene regulation
changes (Zhang et al. 2012). One element of
these transcriptional changes is the activation
of Bcl11b (Ikawa et al. 2010; Li et al. 2010a,b).
BCL11B is a six zinc-finger transcriptional
repressor that is turned on in the late DN2a
stage by Notch signaling, TCF1, RUNX1, and
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GATA3 (Cismasiu et al. 2005; Tydell et al. 2007;
Li et al. 2010b, 2013; Kueh et al. 2016). BCL11B
is needed to finish the process of excluding
cells from potential access to non-T-cell fates
(Ikawa et al. 2010; Li et al. 2010a,b). It induces
down-regulation of Kit expression, thus creat-
ing the DN2b phenotype, and direct binding
of BCL11B at a possible Kit enhancer region
may explain this ability to down-regulate Kit
expression (H Hosokawa, HY Kueh, and EV
Rothenberg, unpubl.). DN2b cells have a slower
proliferation rate and begin to be desensitized to
IL-7R signaling by a mechanism mediated by
E proteins, and survival of DN2b cells becomes
strictly Notch-dependent (Masuda et al. 2007;
Wojciechowski et al. 2007; Yui et al. 2010). The
subsequent DN3a stage is the peak period
for expression of the Notch-dependent and E
protein–dependent genes, such as recombina-
tion activating gene 1 (Rag1), Rag2, Ptcra (en-
coding pre-TCRa), and Cd3e (encoding CD31)
(Takeuchi et al. 2001; Ikawa et al. 2006; Schwartz
et al. 2006; Georgescu et al. 2008; Welinder et al.
2011). Therefore, DN3a cells are committed to
T-cell fate even before expressing TCR on their
surface, but are primedboth forTCRb (orTCRg
andTCRd) gene rearrangement and for success-
ful rearrangement to have an impact (Fig. 1).
Phase 3
The DN3a cells that have achieved successful
V(D)J rearrangement for the TCRb gene ex-
press pre-TCR and proceed to the DN3b stage.
For DN2b and DN3a cells that rearrange both
TCRg and TCRd productively, a separate path-
way leads to development of several functional-
ly distinct subsets of gd T cells (Prinz et al.
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Figure 1. Roles of cytokines and transcription factors (TFs) in three phases of early T-cell development.
Prethymic progenitor cellsmigrate into the thymus and begin T-cell differentiation programunder the influence
of Notch signaling. The earliest T-cell precursors in the thymus are called early thymic progenitor (ETP) or KIT-
high double-negative 1 (KITþþ DN1; CD44þ CD252) and they transit through DN2a, DN2b, DN3a, and
DN3b/4 stages, followed by progression to DP stage. Early T-cell development can be divided into three phases
based on the status of T-lineage commitment and Notch-dependency. The proliferation rate of the cells dy-
namically changes during the three phases and this reflects regulation by cytokine signaling and the phase-
specific transcription factors. TCR, T-cell receptor; IL-7, interleukin-7.
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2013; Vantourout and Hayday 2013). Although
Notch signals are still required initially for pas-
sage through b-selection, cells that are able to
receive signals through the pre-TCR transit
from Notch-dependent to Notch-independent
at this point. They strongly and rapidly turn off
Notch target genes and IL-7R expression (Mail-
lard et al. 2006; Taghon et al. 2006), becoming
DN3b and then DN4 cells.
Signaling from pre-TCR triggers another
shift in the gene regulatory network, transition-
ing into “phase 3.” Despite the shutoff of IL-7R-
and Notch-dependent growth-supporting sys-
tems, the DN4 cells enter a period of very rapid
proliferation that is important for full pheno-
typic differentiation to the next stage (Kreslav-
sky et al. 2012). This is supported in part
by chemokine signaling through CXCL12/
CXCR4 (Janas et al. 2010; Tussiwand et al.
2011). The proliferative burst also appears to
be supported by very dynamic use of TCF1
and LEF1 in what may be a transient, self-lim-
ited canonical Wnt pathway response (Yu et al.
2010), although the details are still under de-
bate. In the process, the cells begin to express
not only the CD4 and CD8 coreceptors but also
two new transcription factors, IKZF3 (Aiolos)
and RORgt, while finally silencing the last of the
DN-specific factors, like ERG and HES1.
In summary, early T-cell development can
be divided into three phases based on the status
of T-lineage commitment and Notch depen-
dency: Notch-dependent precommitted (phase
1), Notch-dependent T-lineage committed
(phase 2), and Notch-independent pre-TCR-
dependent (phase 3) phases (Yui and Rothen-
berg 2014). Each of the phases is associated
with distinct transcription factor ensembles
that are supported by extracellular signaling
provided from the microenvironment in the
thymus. All three phases are essential for proper
abTCRþ T-cell development.
ROLES OF ENVIRONMENTAL SIGNALS AND
TRANSCRIPTION FACTORS IN THE
INITIATIONOFT-CELL PROGRAM—PHASE1
In phase 1, early T cells need to rapidly prolif-
erate to maintain the pool size of pro-T cells,
because only small numbers of T-cell progeni-
tors migrate into the thymus per day. The
microenvironmental signals best established to
support growth of initial thymic immigrants are
Notch ligands and Kit ligand (also called stem-
cell factor [SCF]). ETP cells have a NOTCH1þ
KIThi IL-7Rlow phenotype initially and only
later develop into NOTCH1þ KIThi IL-7Rhi
DN2a cells. Initially, the survival and prolifera-
tion of ETP cells mostly appear to be dependent
on KIT/KIT ligand interaction (Waskow et al.
2002; Massa et al. 2006). Upon entry, thymic
immigrants also express FLT3, but it seems to
be down-regulated midway through the ETP
stage, around the time when adult ETPs lose
B-cell potential (Sambandam et al. 2005; Hein-
zel et al. 2007; Zhang et al. 2012; Mingueneau
et al. 2013; Ramond et al. 2014). Although im-
portant prethymically, FLT3 does not appear to
encounter its ligand in T-cell-promoting niches
within the thymus. However, for cells escaping
T-lineage commitment, FLT3 ligandmay be im-
portant in much rarer, dendritic-cell-promot-
ing intrathymic niches (Lyszkiewicz et al. 2015).
Notch1-DLL4 signaling is not only needed
for viability and to induce genes encoding T-
cell-specific regulatory factors, such as Tcf7,
Gata3, and Bcl11b, but it is also required to
antagonize alternative non-T-lineage develop-
ment through a variety of pathways. A particu-
larly sensitive target is the B-cell pathway
(Mohtashami et al. 2010; Van de Walle et al.
2011), which may be blocked by Notch signal-
ing through at least two distinct mechanisms
(see below) (Hozumi et al. 2008). After this,
ETP and DN2a cells still retain the potential
to develop into dendritic cells, granulocytes,
macrophages, and innate lymphocytes (ILCs),
includingNK cells and possibly mast cells (Shen
et al. 2003; Schmitt et al. 2004; Balciunaite et al.
2005b; Taghon et al. 2007; Bell and Bhandoola
2008; Wada et al. 2008; Luc et al. 2012; Wong
et al. 2012; De Obaldia et al. 2013a), but then
all of these potentialities are also shut off at the
transition from DN2a to DN2b under the
continued influence of Notch signaling, as de-
scribed below.
In view of their differential expression of
KIT and IL-7R, it is notable that both ETP and
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DN2a cells proliferate extensively before com-
mitment, and both KIT ligand and IL-7 from
the thymic microenvironment are crucial for
this early expansion (Prockop and Petrie 2004;
Massa et al. 2006; Calderon and Boehm 2012;
Buono et al. 2016). This proliferation is driven
first by a KITL-predominant microenviron-
ment and then by an IL-7-predominant envi-
ronment (Buono et al. 2016), matching the
shifts in the ratio of KIT to IL-7R as the cells
progress from ETP to DN2a cells. However,
computational modeling suggests that the larg-
est number of cell cycles may take place in the
ETP stage (Manesso et al. 2013), before the cells
activate strong expression of IL-7 receptors.
This suggests that the earliest proliferative ex-
pansion could be amajor function that depends
not only on KIT signaling but also on another
regulatory input in place of IL-7R, and one
possibility is that this is supplied by the phase
1–specific transcription factors. Many of the
transcription factors that are expressed only in
phase 1 have roles in the proliferation, survival,
and self-renewal of other hematopoietic cells
and can be involved in the pathogenesis of
leukemias (Yui and Rothenberg 2014).
Two phase 1–restricted transcription factor
genes that have clear genetically defined roles in
ETP-DN2-stage proliferative expansion are Lyl1
(Zohren et al. 2012) and Hhex (Goodings et al.
2015; Jackson et al. 2015), whereas the factor
encoded by a third gene, Erg, is specifically
implicated in proliferation at the expense of dif-
ferentiation (Knudsen et al. 2015). In addition,
even PU.1 (encoded by Spi1, also known as
Sfpi1), a phase 1–restricted transcription factor
that seems most associated with alternative
differentiation pathways, may also positively
regulate growth of phase 1 pro-T cells, directly
or indirectly. The expression of PU.1 continues
in early DN cells from their prethymic precur-
sors, persisting at high levels through multiple
cell divisions in ETP and DN2a stages, but then
decreasing sharply during T-cell lineage com-
mitment (Yui et al. 2010). PU.1 is normally
associated with the differentiation of dendritic
cells (DCs), myeloid cells, and B cells, and its
expression strongly correlates with the ability of
uncommitted T-cell precursors to differentiate
to DC and myeloid cell fates when Notch sig-
naling is withdrawn (Lefebvre et al. 2005; Fran-
co et al. 2006; Laiosa et al. 2006; Carotta et al.
2010b; Del Real and Rothenberg 2013). Howev-
er, in addition, it is important for the expression
of FLT3 by prethymic precursors (Carotta et al.
2010a), and direct genomic analysis indicates
that it regulates numerous G-protein-coupled
receptors and signaling components as well as
cytokine receptors in phase 1 pro-T cells
(Champhekar et al. 2015). Any of these could
help to explain how PU.1 also positively con-
tributes to early T-cell development (Dakic
et al. 2005; Champhekar et al. 2015).
GATA3 AND THE ESTABLISHMENT OF A
T-CELL-SPECIFIC REGULATORY STATE
Despite the presence of non-T lineage factors,
phase 1 is also the context in which the T-cell
program is first triggered. Notch signaling in
ETP cells initiates the expression of the crucial
regulatory transcription factor genes Gata3 and
Tcf7, which then alter the developmental status
of the cells (Hosoya et al. 2009; Germar et al.
2011). Tcf7 is activated by Notch signaling
directly, and its product, TCF1, primarily acts
as a positive regulator of T-cell specification,
collaborating with Notch to activate T-cell
genes through a feedforward network circuit
(De Obaldia and Bhandoola 2015). GATA3
and TCF1 (encoded by Tcf7) not only begin to
antagonize the progenitor-specific factors, but
they also collaborate with a different group of
regulatory factors required for T-cell develop-
ment that continue expression initiated from
a prethymic stage, such as MYB, RUNX1,
CBFb, IKAROS, GFI1, and E2A. These are sta-
bly expressed as “legacy factors,” but neverthe-
less function in developmentally modulated
ways, as they are incorporated together with
TCF1 and GATA3 into the network of factors
regulating T-cell lineage commitment. Actually,
some of these factors have also been identified as
physically GATA3-interacting molecules in an
early T-cell line (H Hosokawa and EV Rothen-
berg, unpubl.).
GATA3 has indispensable roles not only in
early T-cell development but also throughout
Cytokines, Transcription Factors, and T-Cell Development
Cite this article as Cold Spring Harb Perspect Biol 2018;10:a028621 5
Cold Spring Harbor Laboratory Press 
 at CALIFORNIA INSTITUTE OF TECHNOLOGY on June 4, 2018 - Published byhttp://cshperspectives.cshlp.org/Downloaded from 
T-cell development, with multiple functions in
the thymus and periphery. It works differently
in a broad variety of developmental stages,
affecting early T-cell survival, growth, specifica-
tion, and commitment and in priming DN2
cells for progression to b-selection (Pai et al.
2003; Hosoya et al. 2010; Garcia-Ojeda et al.
2013; Scripture-Adams et al. 2014; Tindemans
et al. 2014). In one of the earliest steps in com-
mitment, Notch signaling- and TCF1-induced
Gata3 expression blocks B-cell lineage develop-
mental potential from ETP cells, very shortly
after their immigration into the thymus (Hein-
zel et al. 2007; Hozumi et al. 2008; Garcia-Ojeda
et al. 2013).
The levels of GATA3 gradually increase in
DN2a-DN2b cells and contribute to both
activation of Bcl11b and repression of Sfpi1
(PU.1) expression to support T-cell specifica-
tion and commitment (Taghon et al. 2007;
Zhang et al. 2012; Li et al. 2013). Knockdown
of Gata3 expression in ETP and DN2 cells
blocks appearance of the DN3 phenotype,
with up-regulation of phase 1 genes, including
Sfpi1 and Bcl11a, and down-regulation of phase
2 genes, such as Ets1, Zfpm1, Il9r, Il17rb, and
Bcl11b (Garcia-Ojeda et al. 2013; Scripture-Ad-
ams et al. 2014). Later, GATA3 is also required
for full TCRb locus activation needed to pass
through b-selection, and for generation of CD4
SP T cells (Pai et al. 2003).
Therefore, GATA3 is a vitally important fac-
tor for early T-cell development, but at least in
themurine system, it has a highly limited dose–
response range inDN cells. This is an interesting
contrast with its roles inmature Th2 cells, where
overexpression is tolerated. Instead, increased
concentrations of GATA3 are as toxic for mouse
early T-cell precursors as loss of GATA3, and if
the overexpressing cells can be kept alive, they
can be driven into becoming mast cells (Taghon
et al. 2007). Thus, T-cell identity is strongly
dependent onGATA3 and also requires the pres-
ervation of strict limits to GATA3 expression.
While GATA3 at modest levels is nearly
universal in T-lineage precursor cells from the
ETP stage onward, its activity may be modulat-
ed in a stage- or signal-dependent way. Recently,
several groups reported that posttranslational
modifications of GATA3 regulate its functions
(Cook and Miller 2010; Kitagawa et al. 2014;
Hosokawa et al. 2015, 2016). Phosphorylation
and acetylation regulate both stability and tran-
scriptional activity of the related GATA1 factor
(Hernandez-Hernandez et al. 2006). Thus, the
functions of GATA3 could be strictly regulated
by several distinct mechanisms in a stage-spe-
cific manner.
AVOIDING DIVERSION TO ALTERNATIVE
FATES IN PHASE 1
Phase 1 cells, still being uncommitted, need
continuous signaling from the microenviron-
ment to stay in the T-cell pathway. Each kind
of alternative pathway needs to be obstructed by
a different mechanism. Within the thymus,
Notch-DLL4 signaling rapidly induces antago-
nists of at least two alternative pathways, GATA3
to block B-cell development and HES1 to block
myeloid development (De Obaldia et al. 2013b;
Garcia-Ojeda et al. 2013; Scripture-Adams et al.
2014). Notch-induced TCF1may also play a role
in blocking access to DC development, at least
(Kueh et al. 2016). Eventually, the cumulative
action of the Notch-triggered regulatory cas-
cade also induces BCL11B (Kueh et al. 2016)
to block NK cell development (Li et al. 2010b).
The up-regulation of these active antagonists of
alternative fates can be viewed as “commitment
by addition.” The possibility of diversion tomy-
eloid and dendritic cell fates is not eliminated at
a cell-intrinsic level, however, until the cells
transition to phase 2, through “commitment
by subtraction,” when the key enabling factor
PU.1 is silenced. Until then, very selective ex-
pression of cytokines in the thymus microenvi-
ronment also provides a safety net. B cells can
potentially grow in the IL-7 provided by cortical
thymic epithelial cells (Calderon and Boehm
2012), if not aborted early by Notch-dependent
mechanisms, but progenitors taking a pathway
that might require myeloid growth factors can-
not expand in the normal thymus where such
factors are largely absent (Lyszkiewicz et al.
2015). In fact, these environmental restrictions
are extremely effective, so that the majority of
phase 1 cells appear not to give rise to any de-
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tectable myeloid progeny in vivo as long as their
development in the thymus is undisturbed
(Schlenner et al. 2010).
Other cytokines besides myeloid growth
factors must also be kept away from developing
pro-T cells. A fraction of phase 1 cells can
respond to the addition of cytokines IL-33
and IL-7 in the presence of Notch signaling to
become ILC2 (Wong et al. 2012). Signals from
IL-33 can redirect the effects of transcription
factors such as GATA3, BCL11B, and TCF1 to
work in the ILC2 program, via induction of Id2
and the gene that encodes orphan nuclear re-
ceptor RORa (Hoyler et al. 2012; Wong et al.
2012; Yang et al. 2013; Walker et al. 2015; Yu
et al. 2015; Zhong and Zhu 2015). Id2 expres-
sion is required to develop all types of ILCs,
which do not use RAG-based gene rearrange-
ment in their development program. ILCs keep
the Rag genes off, at least in part because of
neutralization of E protein activity by Id2 (Die-
fenbach et al. 2014; De Obaldia and Bhandoola
2015; Serafini et al. 2015). In contrast, high lev-
els of BCL11B, exceeding those in any ILC sub-
set, restrain Id2 expression in cells taking the T-
cell pathway (Longabaugh et al. 2017).
PROLIFERATION AND DIFFERENTIATION
IN THE PHASE 1/PHASE 2 TRANSITION:
ROLES OF IL-7/IL-7R SIGNALS
IL-7 plays a key role in the development of early
T cells. Actually, mice lacking IL-7 or IL-7R
show strongly impaired T-cell development
(Peschon et al. 1994; DiSanto et al. 1995; von
Freeden-Jeffry et al. 1995), and IL-7R-deficient
T-cell precursors cannot fill available thymic
niches (Prockop and Petrie 2004; Zietara et al.
2015). Defects in the IL-7R in human are asso-
ciated with a severe combined immunodefi-
ciency syndrome characterized by a complete
lack of T cells (Noguchi et al. 1993; Puel et al.
1998). IL-7 signaling also has critical roles in
both gd T-cell development and in later CD8
lineage choice via induction of transcription
factor Runx3 (Singer et al. 2008).
IL-7R is strongly up-regulated in DN2a, and
the proliferative expansion of the cells at this
stage becomes highly sensitive to the IL-7 level
(Wang et al. 2006). In addition, however, its
signaling modulates the rate of developmental
progression (Balciunaite et al. 2005a; Huang
et al. 2005), and this implies an interaction
with the T-cell specification gene-regulatory
network. IL-7R signaling activates both signal
transducers and activators of transcription
(STAT)5 and phosphatidylinositol 3-kinase
(PI3K) pathways. Both pathways are important:
the PI3K pathway plays a crucial role in prolif-
eration and survival of early T cells (Pallard et al.
1999) and STAT5A/5B are needed for full
population expansion both before and after
b-selection (Yao et al. 2006), as well as being
indispensable for opening of the Tcrg loci for
rearrangement to allow gd T-cell development
(Ye et al. 2001; Kang et al. 2004). Surprisingly,
though, little is known about any other ways
that STAT5A/5B interact with the genes in the
T-cell specification gene network.
Two unresolved questions are: first, whether
IL-7R contributes to the extensive proliferation
that seems to occur in ETPs before IL-7Rexpres-
sion is detectable; and, second, why KIT and
IL-7R signaling activate less rapid proliferation
in DN2b cells than in DN2a cells despite similar
expression of IL-7R. One report has suggested
that KIT and IL-7R can interact physically and
signal as a complex (Jahn et al. 2007). If
responses to IL-7R are actually responses to an
IL-7R/KIT complex, then a high level of KIT
coexpression, only available in phase 1 cells,
may be required to support full IL-7-mediated
proliferation. Alternatively, IL-7R signalingmay
depend on phase 1 transcriptional regulatory
factors to induce proliferation of early T cells.
Desensitization of IL-7R after the phase 1–
phase 2 transition may be important in part
because of cross talk of IL-7 signaling with
transcription factors. There are positive and
negative interactions of IL-7/IL-7R signals
with key T-cell transcription factors. First,
IL-7R-mediated PI3K/AKT signaling has been
reported to induce phosphorylation of GATA3
inmemory Th2 cells (Hosokawa et al. 2016), and
AKT-mediated phosphorylation of GATA3 reg-
ulates organization of GATA3 complexes. Strict
regulation of GATA3 expression and function
is important for survival and proliferation of
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early T cells; thus, IL-7R-mediated phosphory-
lation of GATA3 may have some role in stage-
specific responses to IL-7. Second, IL-7/IL-7R
signaling is known in some conditions to reduce
expression of genes, including Tcf7, Lef1, and
Bcl11b, encoding some phase 2 transcription
factors that have important roles in the phase
2 regulatory network (Yu et al. 2004; Ikawa et al.
2010). This interaction may underlie the ability
of high IL-7 to slow developmental progression
to the DP stage, especially in cells developing
from adult ETPs and bone marrow precursors
(Balciunaite et al. 2005a; Huang et al. 2005).
Despite its relative desensitization during
DN2b and DN3a stages, IL-7R activity remains
a latent contributor to cell survival as long as
Il7r is expressed. As cells enter b-selection, IL-
7R signaling from existing cell-surface receptors
still provides some support for proliferation and
survival of DN3b and DN4 cells, even as tran-
scription of Il7r itself is finally repressed. At this
stage, IL-7/IL-7R signaling enhances survival
and proliferative expansion via induction of
prosurvival factor Bcl2 and by sustaining ex-
pression of nutrient-transport protein-coding
genes, such as Cd98 and Cd71 (Boudil et al.
2015). Therefore, sensitivity and reactivity to
IL-7 are dramatically changed in three phases.
ROLES OF CYTOKINES AND
TRANSCRIPTION FACTORS IN THE
COMMITMENT OF T-CELL LINEAGE
CELLS—PHASE 2
Right after Bcl11b expression is induced by the
combination of Notch signaling, RUNX1,
GATA3, and TCF1 cells transition to the DN2b
stage (Yui et al. 2010; Li et al. 2013; Kueh et al.
2016). DN2b cells proliferate more slowly than
DN2a, and their survival becomes strictly
Notch-dependent (Yui et al. 2010). It is still
not certain whether BCL11B directly represses
most phase 1 regulatory genes or simply dis-
ables signaling that would otherwise maintain
their expression (Longabaugh et al. 2017);
but in either case, its action allows most phase
1–restricted genes to be silenced and enables
the cells to enter a committed DN2b state
(Ikawa et al. 2010; Li et al. 2010a,b).
As DN2a cells progress into the DN2b stage,
they undergo dynamic shifts in the expression
of other transcription factors as well. These are
currently useful landmarks although their func-
tional significance is still not fully understood.
Some of the largest shifts are reciprocal regula-
tion of members of the same factor family. For
example, two ETS family transcription factor
genes, Ets1 and Ets2, are rapidly turned on as
the ETS family gene Sfpi1 is turned off; Gfi1
is turned on as Gfi1b is turned off; Bcl11b is
turned on as Bcl11a is turned off, and Runx1
increases expression as Runx2 and Runx3 de-
crease (David-Fung et al. 2009). The silencing
of Sfpi1 expression, through a mechanism de-
pendent on RUNX factors and possibly GATA3
(Taghon et al. 2007; Huang et al. 2008; Zarnegar
et al. 2010; Scripture-Adams et al. 2014), is
thought to be one of themolecular mechanisms
of alternative lineage exclusion as noted above.
Several mechanisms can amplify Notch
pathway signaling in DN3a cells. In addition
to Notch1, Notch3 is activated at DN3a, largely
by a NOTCH1-derived signal, and this probably
adds to the sensitivity for Notch pathway
signaling. At the same time, the cells become
desensitized to IL-7R-driven mitogenesis in
a process that depends on the basic helix–
loop–helix E protein transcription factors,
E2A and HEB (Wojciechowski et al. 2007).
Whereas E2A (encoded by Tcf3) is expressed
stably, HEB levels (encoded by Tcf12) increase
steadily through the DN stages so that an in-
creasing amount of E2A/HEB heterodimer
can be formed, which is important for b-selec-
tion (Barndt et al. 2000; Braunstein and Ander-
son 2012). The activity of E2A and HEB may
be further boosted in DN3a by the silencing of
a competitive binding partner, Lyl1, one of
the phase 1 genes (Zhong et al. 2007; Yui et al.
2010). E proteins in T-cell precursors work in
collaboration with Notch signals (Ikawa et al.
2006), not antagonistically as proposed in B
cells (Nie et al. 2008), andNotch signaling levels
can only be sustained in this context by strong E
protein activity (Yashiro-Ohtani et al. 2009;
Del Real and Rothenberg 2013). Expression of
E protein–dependent and Notch-dependent
genes, including Ptcra, Rag1, Rag2, terminal de-
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oxynucleotidyl transferase (Dntt) and Cd3e,
markedly increases as the proliferation slows
and the cells proceed to the DN3a stage (Ta-
keuchi et al. 2001; Ikawa et al. 2006; Schwartz
et al. 2006; Georgescu et al. 2008;Welinder et al.
2011; Xu et al. 2013).
The E proteins also activate expression of
growth-inhibitory factors, such as suppressor
of cytokine signaling 1 (Socs1) and Socs3, which
uncouple growth factor receptors like IL-7R
from their signaling pathways. In parallel, they
can directly inhibit cell-cycle activation genes,
and induce cyclin-dependent kinase inhibitors
(Schwartz et al. 2006). The cell-cycle arrest in-
duced by E proteins is important to enable
RAG1/RAG2-mediated recombination of the
TCR genes to take place (Li et al. 1996) as well
as for checkpoint control. Double knockout of
the genes encoding E2A (Tcf3) andHEB (Tcf12)
in DN3 stage not only prevents proliferative
arrest but also enables DN3 cells to undergo
reverse differentiation to return to a highly IL-
7-responsive, DN2-cell-like phenotype (Wojcie-
chowski et al. 2007). However, E protein effects
on TCR expression go beyond their effects on
the cell cycle. Singly, E2A (Tcf3)-deficient cells
have a specific defect in TCRb gene rearrange-
ment (Agata et al. 2007) and are prone to leu-
kemic transformation (Engel and Murre 2004).
To summarize, DN3a cells generated by
phase 2 regulatory processes are committed
to a T-cell fate that is ab lineage biased
and primed for RAG-mediated TCRb gene
rearrangement. To reach this stage, cells require
Notch signaling, GATA3, TCF1, BCL11B, ETS1,
RUNX1, and E2A (Oosterwegel et al. 1991;
Schwartz et al. 2006; Li et al. 2010a,b; Germar
et al. 2011; Zhang et al. 2012; Xu et al. 2013).
The maximal expression of the Cd3 gene cluster
is regulated by E protein, GATA3, TCF1, and
BCL11B, whereas the Rag genes are induced
by E protein and GATA3. Together with Notch
signaling, several transcription factors are in-
volved in TCRb gene rearrangement such as
E2A, HEB, MYB, GATA3, and RUNX1. ETS1
collaborates with RUNX1 to activate the en-
hancer of the TCRb gene (Gu et al. 2000). The
expressions ofHes1,Notch3, and Ptcra are joint-
ly regulated by E protein and Notch signaling. E
proteins are required to promote and sustain
NOTCH1 expression in DN3a stage, and Notch
signaling can be antagonized by the E protein
antagonist Id2. BCL11B at a high level keeps Id2
expression silent and assists activation of Dntt
and the Cd3 gene cluster (Longabaugh et al.
2017) to support transition to the DN3a state.
Thus, most of the T-cell genes are fully activat-
ed, and cell-cycle arrest is induced, by late phase
2 stage. At this stage, RAG1/RAG2-mediated
programmed TCRb (V(D)Jb) gene rearrange-
ment also takes place. In the mouse, only a
minority of phase 2 cells rearrange the Tcrg
and Tcrd genes instead. The cells expressing a
functional pre-TCR on productive rearrange-
ment of the Tcrb gene are able to pass through
the b-selection checkpoint.
ROLES OF TRANSCRIPTION FACTORS IN
PASSING THE b-SELECTION CHECKPOINT
TO PHASE 3
Signaling through the newly expressed pre-TCR
not only disrupts the quiescence of DN3a cells,
but also rapidly shuts off the expression of
Notch target genes in an IKAROS-dependent
manner, and cells proceed to phase 3 (Chari
and Winandy 2008; Kleinmann et al. 2008;
Geimer Le Lay et al. 2014). The burst of prolif-
eration that takes place on b-selection amplifies
clones of cells with productive Tcrb rearrange-
ments to maximize the chance for productive
TCRab diversity. At the same time, it helps ab
T cells to undergo proliferation-dependent
epigenetic changes and to dilute out previous
stores of regulatory molecules that would
otherwise interfere with their new regulatory
state (Kreslavsky et al. 2012). Notch signal–
dependent transcription becomes dispensable,
and many of the transcription factors that
participated in the phase 1 and phase 2 stages
decrease or disappear (Tabrizifard et al. 2004;
Yui and Rothenberg 2004). As cells become DP
thymocytes, repressive histone marks accumu-
late at the promoters of phase 1 and Notch tar-
get genes (Zhang et al. 2012; Vigano et al. 2014),
whereas other sites open (e.g., a set of DP-spe-
cific sites for ETS1) (Cauchy et al. 2015). The
establishment of durable epigenetic changes at
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the T-cell and non-T-cell gene loci makes the
program of T-cell gene expression sustained
and irreversible (Zhang et al. 2012; Vigano
et al. 2014).
As the cells proliferate and become DP,
in response to a combination of TCF1 and b-
catenin, with a required input from MYB, the
cells distinctively activate expression of two
new factors: RORgt (Rorc) and the Ikaros
zinc-finger family member AIOLOS (Ikzf3).
Although most universal T-cell properties have
already been acquired by the cells, they need a
special form of viability support to keep them
alive inDPstage long enough to undergo several
rounds of TCRa gene rearrangement. The com-
bination of MYB, TCF1, high HEB/E2A, and
RORgt helps to induce BCL-XL (Bcl2l1) expres-
sion in the future DP cells to sustain them
through this process (Sun et al. 2000; D’Cruz
et al. 2010; Yuan et al. 2010; Wang et al. 2011)
and to arm them for positive selection. Thus, a
new regulatory state prepares DP thymocytes
for the complex positive and negative selection
events that they must undergo.
REGULATING T-CELL PRECURSOR FLUX:
GLIMPSES INTO THE EARLIEST PORT OF
THYMOCYTE ENTRY
One domain in which microenvironmental
cues may be most important for controlling
T-cell generation remains relatively mysterious.
This is the initial entry port for immigrants into
the thymus. Early T-cell development is coordi-
nated with migration through distinct thymic
microenvironments (Fig. 2) (Petrie and Zuniga-
Pflucker 2007; Love and Bhandoola 2011). In
postnatal mammals, immigrant precursors ini-
tially enter the thymus through blood vessels
near the corticomedullary junction (Fig. 2,
right), drawn possibly by chemokine receptor
signaling from CCR7 and CCR9 (Uehara et al.
2002; Schwarz et al. 2007; Krueger et al. 2010;
Zlotoff et al. 2010). Although the numbers of
cells involved are small, it appears that ETP cells
undergo expansion with minimal differentia-
tion in this corticomedullary junction region,
and then, days later, differentiate into DN2a
cells that can begin their migration from the
site of entry deep within the cortex to the outer
rim of the cortex. b-selection occurs during the
accumulation of the DN3 cells when they reach
the extreme outer portion of the thymus. A di-
rectional reversal of migration back across the
cortex toward the medulla occurs for the later
stages of thymocyte development. Thus, for ex-
ample, the different requirements for IL-7 may
be accommodated in vivo by varying amounts
of IL-7 in combination with other extracellular
signals, including adhesive molecules, chemo-
kines, and cytokines provided by different mi-
croenvironments (Zamisch et al. 2005; Alves
et al. 2009; Griffith et al. 2009; Love and Bhan-
doola 2011).
This pattern is different in the early fetal
thymus, where precursors enter directly into
the thymic rudiment by migrating across the
mesenchyme from the outside, before the organ
is vascularized and before the capsule forms
a barrier (Fig. 2) (Anderson et al. 2006). In
the fetus, elegant mutant-rescue experiments
indicate that the crucial genes that the epitheli-
um must express to support T-cell differentia-
tion are DLL4, KIT ligand (KITL), CXCL12,
and CCL25 (i.e., ligands for NOTCH1, KIT,
CXCR4, and CCR9, respectively) (Calderon
and Boehm 2012). However, it is not clear that
this fetal environment behaves equivalently to
the postnatal one. First-wave fetal thymocytes
differentiate faster than late-fetal or postnatal
thymocytes (Watanabe et al. 1997; Ramond
et al. 2014; Scripture-Adams et al. 2014), and
they begin to carryout TCR gene rearrangement
after fewer rounds of proliferation once they
have entered the thymus (Lu et al. 2005). At least
part of this difference is cell-intrinsic, because
fetal thymocytes also differentiate faster when
they are compared on the “level playing field” of
the OP9-DLL1 artificial stroma coculture sys-
tem (Schmitt and Zuniga-Pflucker 2002), and
there are subtle but real differences in gene
expression at corresponding developmental
stages (David-Fung et al. 2006; Belyaev et al.
2012; Ramond et al. 2014; Scripture-Adams
et al. 2014). First-wave fetal thymocytes also
rearrange a particular subset of TCRg genes
that are almost never used after birth. However,
in the adult thymus, the specific transition from
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ETP to DN2 is disproportionately slower than
in the fetus. In steady state, postnatal mouse
ETPs take at least 7–10 days before they shift
to the DN2a stage, although progression to
subsequent stages may require only 2 days
per step (Porritt et al. 2003; Manesso et al.
2013). By contrast, the ETP to DN2a transition
takes no more than 1–2 days in the fetus. This
postnatal-specific extension of the ETP period
is poorly reproduced in the OP9-DLL1 or OP9-
DLL4 culture system, where most of the extend-
ed proliferation takes place in the DN2a/2b
stages. In fact, one of the differences between
“ETP” cells growing on OP9-DLL1 and those
harvested ex vivo is the weaker expression of
FLT3, KIT, and several other stem or progeni-
tor-cell regulatory genes in vitro that are nor-
mally ETP specific in vivo (Zhang et al. 2012;
Mingueneau et al. 2013).What is clearly missing
in the OP9-DLL1 culture is an equivalent of the
entry compartment. Thus, it is exciting that
there is evidence that particular niches in the
adult thymic microenvironment not only limit
the carrying capacityof the thymus (Zietara et al.
2015) but also preserve the immature ETPstatus.
Normally, all entering cells differentiate or
die: self-renewing stem cells do not persist in
the initial entry compartment. However, two
groups showed recently that the niche itself
can support extremely prolonged self-renewal
cTEC KitL+ VEC
Capsule and
trabeculae
?
Fetal first wave
T lineage
    biased
Rapidly committed
Rapid
   developing
Multilineage
Slowly
   committed 
Extensively
   proliferating
Entry through
mesenchyme 
Entry via
blood
Postnatal
mTEC
Figure 2. Fetal and postnatal pathways for progenitor entry into the thymus. Thymic epithelial function is
established in embryonic life and maintained through postnatal life by genes controlled by the FOXN1 tran-
scription factor, but the interactions between the thymic microenvironment and immigrating T-cell precursors
are not the same in fetal and adult life. (Left) Schematic showing pathway of entry and cells involved in
interactions of initial wave of T-cell precursors with the E12-14 fetal mouse thymic microenvironment. (Right)
Same for pathways and interactions between postnatal T-cell precursors and the young adult (4–8 wk old)
mouse thymus. Emphasis is on the cortex where progenitors undergo T-lineage commitment and the interac-
tions controlling traffic into this domain. Medullary structure (pale green, right panel only) develops after the
entry of the first-wave fetal thymic immigrants. Cyan arrows: major pathways of entering precursors, through T-
cell lineage commitment. A thin cyan arrow indicates possible self-renewal pathway within entry compartment
(right). Thin black arrows represent locations of T-cell receptor (TCR)-dependent phases of T-cell development
in the postnatal thymus (right): b-selection, positive selection in the cortex leading to migration into the
medulla, and medullary maturation events including selection and preparation for export. Locations of cortical
thymic epithelial cells (cTEC), KITLþ vascular endothelial cells (KITLþVEC), medullary thymic epithelial cells
(mTEC), and the connective tissue elements of the thymus (capsule and trabeculae, right panel only) are
indicated. See text for details.
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in cases where there is no competition from new
waves of immigrating precursors from the bone
marrow (Martins et al. 2012; Peaudecerf et al.
2012). Thus, it is possible that the initial entry
compartment, the ETP niche, intrinsically sup-
ports expansion and delays differentiation. If
this is true, then it provides something distinc-
tive other than a Notch ligand. The recent
definition of markers that distinguish the cells
forming these initial entry niches (Buono et al.
2016) can help greatly to characterizewhat these
self-renewal cues may be.
Recently, cells expressing the membrane-
bound form of Kit ligand (mKITL) were report-
ed in a specific subdomain of the thymus, which
may represent the entry port for thymus-seed-
ing cells (Buono et al. 2016). Membrane-bound
KITL is known to be more potent than secreted
KITL, similar to other surface-tethered cyto-
kines in the bone marrow microenvironment.
Surprisingly, a subset of vascular endothelial
cells (VECs) in the cortex specifically expresses
both DLL4 Notch ligands and mKITL, and they
act as a specific niche for ETP cells. VEC-spe-
cific deletion of the KitL gene results in a
significant decrease of the number of ETP cells
in the thymus. DN2a cells, on the other hand,
are supported by IL-7-expressing cortical thy-
mic epithelial cells (cTECs), which also express
DLL4 but at lower levels than on the VECs, and
express a higher fraction of KITL in the less-
potent soluble form (Buono et al. 2016). Both
the KITLþ VECs and the cTECs express one
important lymphocyte-supporting chemokine,
CXCL12 (ligand for the CXCR4 chemokine
receptor), but the cTECs express much more
CCL25 (ligand for the CCR9 chemokine recep-
tor) (Buono et al. 2016), which is also impor-
tant for T-cell development. These results
suggest that early T cells migrate inside of the
thymus through stage-specific niches that may
provide them with differentially optimized re-
gimes of extracellular signaling. Specific niches
for DN2b, DN3, and DN4 have not been re-
ported yet, but it is assumed that there are some
niches to support their proliferation, survival,
and construction of stage-specific gene regula-
tory networks.
Importantly, lacking the vascular endothe-
lial entry compartment, the initial port of entry
in the fetal thymus appears to be the immature
cortical thymic epithelium itself. Thus, the ini-
tial compartment in which the ETP to DN2
transition occurs is different in the adult and
fetal thymuses. One interesting possibility is
that the lack of a VEC entry compartment itself
promotes the rapid kinetics of fetal T-cell
differentiation. This speculation remains to be
tested, but one possibility is that signals provid-
ed by the adult entry niche actually retard dif-
Table 1. Expression of cytokine receptors in early T-cell precursors
ETP DN2a DN2b DN3a DN3b DN4
Flt3 High!low Neg Neg Neg Neg Neg
Kit High High Mid Low Neg Neg
IL-7R Low High High High High Neg
IL-4R High High High Low Low Mid
IL-9R Low (mid in fetal) Low (mid in fetal) Low (mid in fetal) Low Low Mid
PDGFRb High High Mid Mid Low Low
gc (Il2rg) High High High High High High
IL-2Ra (CD25) Low High High High High!mid Neg
IL-2Rb Neg Neg Neg Neg Neg Neg
PDGFRa Neg Neg Neg Neg Neg Neg
Data are based onRNA-seq (Zhang et al. 2012) andmicroarray (Mingueneau et al. 2013)measurements ofmessenger RNAs
(mRNAs) encoding the indicated receptors. Data for early thymic progenitor (ETP) and DN2 subsets derived from fetal liver
precursors were from (Zhang et al. 2012). The gc chain (CD132, encoded by Il2rg) is the common heterodimer partner of the
interleukin-7 receptor (IL-7R)a, IL-4Ra, and IL-9Ra chains. Regarding IL-2Ra, asterisks indicate that these early T-lineage
cells do not express functional IL-2 receptors evenwhen they express high gc and IL-2Ra, because they do not express IL-2Rb,
which is a required functional component of both the IL-2R and the IL-15R. Neg: Negative (,1 fpkm).
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ferentiation to enable more extensive prolifera-
tion, and that transition out of a potentially self-
renewing early-ETP regulatory state depends on
release from this compartment.
The nature of such signals is still far from
clear. One approach is via analysis of receptors
expressed by the ETPs themselves. Based on our
RNA-seq data, we found that ETPs express Il4ra,
Pdgfrb, and possibly Il9r (Table 1), receptors
whose roles in early T-cell development have
not been clarified yet (Zhang et al. 2012). Re-
cent RNA-seq data suggest that the two niches
for phase 1 cells, VEC and mTEC, differentially
express Pdgf family ligands (Fig. 3). Whether or
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Figure 3.High specialization of different intrathymic phase 1 niches in postnatal mice: distinct gene expression
patterns of Pdgf family ligands in niche cells for early entrants and differentiating phase 1 cells. RNA-sequencing
tracks for themembrane-bound form of Kit ligand (mKITL)-expressing vascular endothelial cells (VECs) (early
thymic progenitor [ETP] niche), and cortical thymic epithelial cells (cTECs) (DN2a niche) (Buono et al. 2016)
were mapped against the murine (mm9) genome (National Center for Biotechnology Information [NCBI]
build 37) on the University of California, Santa Cruz (UCSC) genome browser. Expression patterns of platelet-
derived growth factor (PDGF) family ligands are shown. PDGF-B and -D RNAs were strongly detected in
mKITL-expressing VEC cells, and PDGF-A and -C were preferentially expressed in mKITL-expressing cTEC.
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not these particular ligand–receptor pairs con-
trol the starting gate for T-cell development,
they offer fascinating hypotheses for explora-
tion (H Hosokawa, M Yui, and EV Rothenberg,
unpubl.).
CONCLUDING REMARKS
Early T-cell development is divided into three
phases, based on Notch dependency and status
of T-cell commitment, and all of the three
phases are essential for proper T-cell develop-
ment in the thymus. Inside of the thymus, pro-
T cells undergo programmed migration and
are supported by stage-specific microenviron-
ments, which at a minimum provide Notch
ligands and cytokine signaling. It is clear that
stage-specific microenvironments are involved
in the establishment of the stage-specific gene
regulatory network. However, a great deal is yet
to be explained and understood. Why is the
effect of IL-7 on proliferative expansion of early
T cells different in distinct stages? How are
stage-specific transcription factors induced by
extracellular signaling? And how are stage-spe-
cific roles of stably expressed transcription fac-
tors like GATA3 regulated by extracellular sig-
naling? Are there any specific niches for DN2b,
DN3, and DN4 cells as well as, possibly, for
ETPs? What are the novel molecules provided
by niches that support and regulate early T-cell
development?
T-cell development requires a specific or-
gan, the thymus, which provides well-regulated
stage-specific microenvironments to T-cell pro-
genitor cells. To understand T-cell development
in perspective, it is important to address more
deeply the molecular basis of cross talk between
the extracellular signaling from the microenvi-
ronment and the cell-intrinsic gene regulatory
networks in pro-T cells.
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